<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://idwiki.org/index.php?action=history&amp;feed=atom&amp;title=Fidaxomicin</id>
	<title>Fidaxomicin - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://idwiki.org/index.php?action=history&amp;feed=atom&amp;title=Fidaxomicin"/>
	<link rel="alternate" type="text/html" href="https://idwiki.org/index.php?title=Fidaxomicin&amp;action=history"/>
	<updated>2026-05-12T22:33:00Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://idwiki.org/index.php?title=Fidaxomicin&amp;diff=11688&amp;oldid=prev</id>
		<title>Aidan at 14:57, 8 April 2026</title>
		<link rel="alternate" type="text/html" href="https://idwiki.org/index.php?title=Fidaxomicin&amp;diff=11688&amp;oldid=prev"/>
		<updated>2026-04-08T14:57:45Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 14:57, 8 April 2026&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;
  &lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;
  &lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Antibiotics indicated for [[Clostridioides difficile]] infection&lt;/div&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Antibiotics indicated for [[Clostridioides difficile]] infection&lt;/div&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Standard dose is 200 mg p.o. twice daily for 10 days&lt;/div&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Standard dose is 200 mg p.o. twice daily for 10 days&lt;/div&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Pulse-tapered regimen is 200 mg twice daily for days 1 to 5, followed by 200 mg every other days 7 to 25[[CiteRef::guery2018ex]][[CiteRef::skinner2021a]]&lt;/div&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Pulse-tapered regimen is 200 mg twice daily for days 1 to 5, followed by 200 mg every other days 7 to 25[[CiteRef::guery2018ex]]&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;, or 200 mg twice daily for 10 days then daily for 7 days then every other day for 13 doses&lt;/ins&gt;[[CiteRef::skinner2021a]]&lt;/div&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* In Ontario, EAP criteria for approval through the telephone request service includes: third or subsequent episode treated with vancomycin within 6 months; treatment failure despite at least 7 days of vancomycin; allergy to oral vancomycin; severe adverse reaction or intolerance to oral vancomycin&lt;/div&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* In Ontario, EAP criteria for approval through the telephone request service includes: third or subsequent episode treated with vancomycin within 6 months; treatment failure despite at least 7 days of vancomycin; allergy to oral vancomycin; severe adverse reaction or intolerance to oral vancomycin&lt;/div&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br /&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br /&gt;&lt;/td&gt;
&lt;/tr&gt;

&lt;!-- diff cache key site7_mediawiki:diff:1.41:old-11686:rev-11688:wikidiff2=table:1.13.0:bc2a06be --&gt;
&lt;/table&gt;</summary>
		<author><name>Aidan</name></author>
	</entry>
	<entry>
		<id>https://idwiki.org/index.php?title=Fidaxomicin&amp;diff=11686&amp;oldid=prev</id>
		<title>Aidan at 14:54, 8 April 2026</title>
		<link rel="alternate" type="text/html" href="https://idwiki.org/index.php?title=Fidaxomicin&amp;diff=11686&amp;oldid=prev"/>
		<updated>2026-04-08T14:54:46Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 14:54, 8 April 2026&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;
  &lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;
  &lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Antibiotics indicated for [[Clostridioides difficile]] infection&lt;/div&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Antibiotics indicated for [[Clostridioides difficile]] infection&lt;/div&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Standard dose is 200 mg p.o. twice daily for 10 days&lt;/div&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Standard dose is 200 mg p.o. twice daily for 10 days&lt;/div&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Pulse-tapered regimen is 200 mg &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;once&lt;/del&gt; daily for &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;7&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;days&lt;/del&gt; followed by 200 mg&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt; fidaxomicin&lt;/del&gt; every other &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;day&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;for the remaining&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;13&lt;/del&gt; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;doses&lt;/del&gt;[[CiteRef::skinner2021a]]&lt;/div&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Pulse-tapered regimen is 200 mg &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;twice&lt;/ins&gt; daily for &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;days&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;1 to 5,&lt;/ins&gt; followed by 200 mg every other &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;days&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;7&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;to&lt;/ins&gt; &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;25[[CiteRef::guery2018ex]]&lt;/ins&gt;[[CiteRef::skinner2021a]]&lt;/div&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* In Ontario, EAP criteria for approval through the telephone request service includes: third or subsequent episode treated with vancomycin within 6 months; treatment failure despite at least 7 days of vancomycin; allergy to oral vancomycin; severe adverse reaction or intolerance to oral vancomycin&lt;/div&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* In Ontario, EAP criteria for approval through the telephone request service includes: third or subsequent episode treated with vancomycin within 6 months; treatment failure despite at least 7 days of vancomycin; allergy to oral vancomycin; severe adverse reaction or intolerance to oral vancomycin&lt;/div&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br /&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br /&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Aidan</name></author>
	</entry>
	<entry>
		<id>https://idwiki.org/index.php?title=Fidaxomicin&amp;diff=11234&amp;oldid=prev</id>
		<title>Aidan: Created page with &quot;* Antibiotics indicated for Clostridioides difficile infection * Standard dose is 200 mg p.o. twice daily for 10 days * Pulse-tapered regimen is 200 mg once daily for 7 days followed by 200 mg fidaxomicin every other day for the remaining 13 dosesCiteRef::skinner2021a * In Ontario, EAP criteria for approval through the telephone request service includes: third or subsequent episode treated with vancomycin within 6 months; treatment failure despite at least 7 days...&quot;</title>
		<link rel="alternate" type="text/html" href="https://idwiki.org/index.php?title=Fidaxomicin&amp;diff=11234&amp;oldid=prev"/>
		<updated>2025-08-19T15:48:06Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;* Antibiotics indicated for &lt;a href=&quot;/Clostridioides_difficile&quot; title=&quot;Clostridioides difficile&quot;&gt;&lt;i&gt;Clostridioides difficile&lt;/i&gt;&lt;/a&gt; infection * Standard dose is 200 mg p.o. twice daily for 10 days * Pulse-tapered regimen is 200 mg once daily for 7 days followed by 200 mg fidaxomicin every other day for the remaining 13 doses&lt;a href=&quot;/index.php?title=CiteRef::skinner2021a&amp;amp;action=edit&amp;amp;redlink=1&quot; class=&quot;new&quot; title=&quot;CiteRef::skinner2021a (page does not exist)&quot;&gt;CiteRef::skinner2021a&lt;/a&gt; * In Ontario, EAP criteria for approval through the telephone request service includes: third or subsequent episode treated with vancomycin within 6 months; treatment failure despite at least 7 days...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;* Antibiotics indicated for [[Clostridioides difficile]] infection&lt;br /&gt;
* Standard dose is 200 mg p.o. twice daily for 10 days&lt;br /&gt;
* Pulse-tapered regimen is 200 mg once daily for 7 days followed by 200 mg fidaxomicin every other day for the remaining 13 doses[[CiteRef::skinner2021a]]&lt;br /&gt;
* In Ontario, EAP criteria for approval through the telephone request service includes: third or subsequent episode treated with vancomycin within 6 months; treatment failure despite at least 7 days of vancomycin; allergy to oral vancomycin; severe adverse reaction or intolerance to oral vancomycin&lt;br /&gt;
&lt;br /&gt;
[[Category:Antibiotics]]&lt;/div&gt;</summary>
		<author><name>Aidan</name></author>
	</entry>
</feed>